Effect of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 27, 2017

Primary Completion Date

May 12, 2017

Study Completion Date

May 12, 2017

Conditions
Diabetes Mellitus
Interventions
DRUG

Sotagliflozin (SAR439954)

"Pharmaceutical form: tablets~Route of administration: oral"

DRUG

Rifampicin

"Pharmaceutical form: capsules~Route of administration: oral"

Trial Locations (1)

38610

Investigational Site Number 250001, Gières

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY